Marinko Jagić is the new CEO of Lura Group, a company owned by Luka Rajić, and new members of the Management Board have also been appointed, Vice President Vesna Žuvela and Management Board member Ivan Kliček.
According to Lura Group, Jagić comes to this position from AstraZeneca, one of the largest global pharmaceutical companies, where he served as the finance director for Southeast Europe. At AstraZeneca, he held other key positions since 2004, including a member of the Management Board of AstraZeneca Hungary and CEO of AstraZeneca Croatia. Before AstraZeneca, he worked for seven years in leading positions at Coca-Cola Adria, including as CEO. In addition to the aforementioned companies, he has also worked at Pfizer and HNB. Last year, he completed a professional development program on leadership in the pharmaceutical industry and biotechnology at Harvard, and he is currently preparing a doctorate at the University of Zagreb in the field of finance and marketing.
– I am happy that a person who will contribute to the further development of the companies with his experience and knowledge is coming to the leading position. We are pleased that through Lura Group we have found new concepts, optimized operations, and enabled more efficient management, which represents an important step in the further development of the Group’s members. Through the synergy of operations via the parent company, we have added value to investments and contributed to the further development of modern companies that will successfully compete in the domestic and European markets, said Luka Rajić to the media regarding the appointment of the new CEO.
